An Australian-German team of scientists has found a way to measure the attention span of a fly. The findings could lead to further advances in the understanding of attention-deficit hyperactivity disorder (ADHD) and autism in humans.
16 Vote(s)
January 26, 2010
January 13, 2010
Cardiac Risk of Stimulants for Children With ADHD:
New guidelines to assess cardiac risk before using stimulant medication in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) were published concurrently in 3 Canadian medical society journals in November. Publication of these guidelines coincided with an FDA announcement of a delay in a US epidemiological study of the potential cardiovascular risk.
7 Vote(s)
7 Vote(s)
Comments Off
January 12, 2010
Disconnect between brain regions in ADHD
Two brain areas fail to connect when children with attention deficit hyperactivity disorder attempt a task that measures attention, according to researchers.
7 Vote(s)
7 Vote(s)
Comments Off
January 8, 2010
New Treatment For Hyperactivity In Children
A new thought-operated computer system which can reduce the symptoms of Attention Deficit Hyperactivity Disorder (ADHD) in children will be rolled out across the UK this month...
5 Vote(s)
5 Vote(s)
Comments Off
New treatment for hyperactivity in children: Thought-operated computer system
A new thought-operated computer system which can reduce the symptoms of Attention Deficit Hyperactivity Disorder (ADHD) in children is being be rolled out across the UK.
16 Vote(s)
16 Vote(s)
Comments Off
November 14, 2009
Shire Reports Analysis Examining Emotional Lability In Children With ADHD Taking Vyvanse
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse®. In this study, Vyvanse demonstrated significant improvement in Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms as measured by the ADHD Rating Scale IV (ADHD-RS IV) and Connors' Parent Rating Sc
9 Vote(s)
9 Vote(s)
Comments Off
October 24, 2009
ADHD: Vyvanse Capsules CII Administration Through 2 Routes Demonstrated Similar Pharmacokinetic Profile
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced new data about the pharmacokinetics of its Attention-Deficit/Hyperactivity Disorder (ADHD) medication, Vyvanse® (lisdexamfetamine dimesylate) Capsules CII, which showed that Vyvanse provided similar concentrations of its active medication in the blood when administered either intranasally or when admini
6 Vote(s)
6 Vote(s)
Comments Off
October 23, 2009
New Study On Vyvanse(R) (lisdexamfetamine Dimesylate) Capsules CII Shows Administration Of Vyvanse Through Two Different Routes
Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced new data about the pharmacokinetics of its Attention-Deficit/Hyperactivity Disorder (ADHD) medication, Vyvanse® (lisdexamfetamine dimesylate) Capsules CII, which showed that Vyvanse provided similar concentrations of its active medication in the blood when administered either intranasally or when admini
7 Vote(s)
7 Vote(s)
Comments Off
October 6, 2009
Psychiatric Symptoms May Predict Internet Addiction In Adolescents
Adolescents with psychiatric symptoms such as attention-deficit/hyperactivity disorder, social phobia, hostility and depression may be more likely to develop an Internet addiction, according to a new report.
7 Vote(s)
7 Vote(s)
Comments Off
September 15, 2009
Alterations In Brain Dopamine Pathway Appears To Be Associated With Certain Symptoms Of ADHD
Results from brain scans suggest an association between a reduction in the transmission of dopamine markers with symptoms of inattention for individuals with attention deficit/hyperactivity disorder (ADHD), according to a preliminary study in the September 9 issue of JAMA. ADHD is a childhood psychiatric disorder that frequently persists into adulthood, and is estimated to affect 3 percent t
9 Vote(s)
9 Vote(s)
Comments Off